Anavex Life Sciences Corp (AVXL)

[B60611]

Clintrials dates are a joke and there doesn’t seem to be any effort by Anavex or their CRO to update accurately or in a timely fashion. Rather, they half-ass it after the fact. The PR for PDD completed enrollment was 1/27/20. 14 weeks after that was 5/4/2020. Build in 2 weeks on either side for washout and last visits and you’ve got 6/1/20. On 9/1/20 they changed clintrials to say the trial’s estimated ending was on 9/30/20 and on 10/19/20 they confirmed that as the actual trial ending. Seriously, wtf? The first bare-bones PR for positive results was 10/15/20 (19.5 weeks later and before they updated clintrials) and they presented at CTAD on 11/6/20.

It’s hard to use PDD to gauge potential dates for ALZ TLD, but if they do end up being similar we’re talking first TLD PR around the last week of October

Missling is a piece of work but his first priority needs to be getting the TLD to the public / shareholders. He has no business postponing release until CTAD, and he’ll have ample opportunity to release follow-on data at the conference. He needs to stop effing around and treat the 2/3 data like a real company would, not his personal play thing.